IOVS Clinical and Diagnostic Laboratory Immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nonaka, A.
Right arrow Articles by Ogura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nonaka, A.
Right arrow Articles by Ogura, Y.
(Investigative Ophthalmology and Visual Science. 2002;43:1204-1209.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Inflammatory Response after Scatter Laser Photocoagulation in Nonphotocoagulated Retina

Atsushi Nonaka1, Junichi Kiryu1, Akitaka Tsujikawa1, Kenji Yamashiro1, Kazuaki Nishijima1, Hiroshi Kamizuru1, Yoshiaki Ieki1, Kazuaki Miyamoto1, Hirokazu Nishiwaki1, Yoshihito Honda1 and Yuichiro Ogura2

1 From the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan; and the 2 Department of Ophthalmology, Nagoya City University Medical School, Nagoya, Japan.


   Abstract
Top
 Abstract
Introduction
 Methods
 Results
 Discussion
 References
 
PURPOSE. Macular edema is one of the most serious adverse effects after retinal scatter laser photocoagulation. It has been suggested that the changes in the distribution of retinal blood flow or the inflammatory reaction after photocoagulation may be involved in the pathogenesis of macular edema, but little information is available about its exact mechanism. This study was designed to evaluate quantitatively leukocyte-endothelial cell interactions and vascular permeability in the nonphotocoagulated portions of the retina after partial scatter laser photocoagulation.

METHODS. Argon laser photocoagulation was performed in one half of the retina in male pigmented rats (n = 90). In the other half of the retina, leukocyte dynamics after photocoagulation were evaluated in vivo with acridine orange digital fluorography. Retinal vessel permeability was quantified by using Evans blue dye.

RESULTS. Scatter laser photocoagulation caused significant inflammatory leukocyte-endothelial interactions not only in the photocoagulated but also in the untreated half of the retina. In the nonphotocoagulated half of the retina, the number of leukocytes rolling along the major retinal veins increased after photocoagulation and peaked at 12 hours (14.3 ± 4.5 cells/min per vessel). Leukocyte accumulation in the untreated half of the retina increased after photocoagulation, with a peak of 47.5 ± 13.0 cells/mm2 24 hours after photocoagulation. Retinal vascular permeability in the untreated half of the retina gradually increased after photocoagulation.

CONCLUSIONS. Scatter laser photocoagulation increased leukocyte rolling and subsequent accumulation in both the photocoagulated and the untreated portions of the retina. The accumulated leukocytes may be involved in the augmented vascular permeability in the untreated retina, resulting in retinal edema after photocoagulation.


   Introduction
Top
 Abstract
 Introduction
Methods
 Results
 Discussion
 References
 
Scatter laser photocoagulation is widely used for the treatment of various retinal diseases, such as diabetic retinopathy, retinal artery or vein occlusion, and retinopathy of prematurity. Despite the treatment’s significant suppressive effect against neovascularization, macular edema is recognized as a potential side effect of scatter photocoagulation, resulting in transient or persistent visual disturbance.1 According to a recent report by Tsujikawa et al.,2 60% of eyes treated with scatter photocoagulation showed an increase in foveal thickness, detectable by a scanning retinal thickness analyzer, after photocoagulation. In general, scatter laser photocoagulation is used outside the retinal vascular arcade, but the retina at the posterior pole often increases in thickness after laser photocoagulation. Although it has been suggested that autoregulatory changes in distribution of retinal blood flow are involved in the pathogenesis of postlaser macular edema, the exact mechanism remains unclear.

A pathogenic mechanism for the development of macular edema has been suggested to be the postlaser inflammatory reaction in the retina.1 Recently, the inflammatory factors, in addition to direct effects on junctional permeability, were shown to cause inflammatory barrier disruption by leukocyte-mediated mechanisms.3 The inflammatory factors produced in the coagulated peripheral region may induce the upregulation of endothelial adhesion molecules in the nonphotocoagulated posterior pole retina as well as the coagulated peripheral retina, resulting in leukocyte recruitment to the macula. Subsequently, accumulated leukocytes in the posterior pole may contribute to the breakdown of the retinal endothelial cell barrier, resulting in macular edema after scatter laser photocoagulation.3

We have developed a method of acridine orange digital fluorography that allows us to visualize leukocytes and to evaluate quantitatively their behavior in the retinal microcirculation in vivo.4 5 6 7 8 Using this method, Hiroshiba et al.9 previously demonstrated impaired leukocyte flow in the untreated portion of the retina after partial scatter laser photocoagulation. We hypothesized that accumulated leukocytes in the nonphotocoagulated posterior pole would play a role in the pathogenesis of macular edema after scatter laser photocoagulation. In the present study, after application of scatter laser photocoagulation in one half of the retina, we evaluated quantitatively the inflammatory leukocyte-endothelial cell interactions in the untreated half of the retina. In addition, we also investigated the vascular permeability after photocoagulation in the untreated half of the retina by means of a recently reported sensitive method in which Evans blue is used to quantitate blood-retinal barrier breakdown.10


   Methods
Top
 Abstract
 Introduction
 Methods
Results
 Discussion
 References
 
Animal Model
All procedures conformed to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Male pigmented Long-Evans rats, weighing 200 to 250 g (n = 90), were anesthetized with a mixture (1:1) of xylazine hydrochloride (4 mg/kg) and ketamine hydrochloride (10 mg/kg). The pupils were dilated with 0.5% tropicamide and 2.5% phenylephrine hydrochloride. A contact lens was placed on the cornea to maintain transparency, and body temperature was kept at between 38 ± 0.5°C throughout the experiments.

Argon laser photocoagulation was delivered through a slit lamp biomicroscope equipped with a 90-D fundus lens. Scatter laser burns were placed in half of the retina and the other half was left untreated. The laser treatment was applied at the following settings: spot size, 100 µm; duration, 0.05 seconds; and power, 40 mW.9 The spots were placed 1 or 1.5 spot diameters peripherally from the optic disc. Only one eye was treated in each animal.

Acridine Orange Digital Fluorography
At 4, 12, 24, 48, and 168 hours after 400 spots of photocoagulation were applied, acridine orange digital fluorography was performed. Six eyes of six different rats were examined at each time point. To examine a dose response with total number of photocoagulation in leukocyte dynamics, acridine orange digital fluorography was performed at 24 hours after 100, 200, and 300 spots of photocoagulation. Six eyes of six different rats were examined for each amount of photocoagulation. Six rats without photocoagulation served as the control.

Acridine orange digital fluorography has been described in detail.5 6 Acridine orange (0.1% solution in saline; Wako Pure Chemicals, Osaka, Japan) was injected continuously through a catheter inserted into the tail vein for 1 minute at a rate of 1 mL/minute. The fundus was observed with a scanning laser ophthalmoscope (Rodenstock Instruments, Munich, Germany) in the 40° field for 5 minutes. Because the dye emits a green fluorescence when it interacts with DNA, the argon blue laser was used for the illumination source. Immediately after intravenous injection of acridine orange, leukocytes were stained selectively among the circulating blood cells. Nuclei of vascular endothelial cells also were stained. At 30 minutes after injection, the fundus was observed again to evaluate leukocyte accumulation in the retinal microcirculation. The images obtained were stored on an S-VHS videotape at a rate of 30 frames/sec for further analysis.

After the laser ophthalmoscopic images were obtained, rats were killed with an overdose of anesthesia. Eyes were enucleated to determine a calibration factor to convert data measured on a computer monitor (in pixels) into real data (in micrometers).

Image Analysis
The video recordings were analyzed with a computer-assisted image analysis system that obtains continuous high-resolution images of fundus stained by acridine orange, as described in detail elsewhere.5 6 In brief, the system consists of a computer equipped with a video digitizer (Radius, San Jose, CA) that digitizes the video image in real time to 640 horizontal and 480 vertical pixels with an intensity resolution of 256 steps. Using this system, we evaluated the diameters of the major retinal vessels, the flux of rolling leukocytes along the major retinal veins, and the number of leukocytes that had accumulated in the retinal microcirculation. We evaluated these parameters separately in either the photocoagulated or nonphotocoagulated half of the retina.

Diameters of major retinal vessels were measured at 1 disc diameter from the center of the optic disc. Each vessel diameter was calculated as the distance between endothelial cells stained by acridine orange on each side of the vessel. The averages of the individual arterial and venous diameters in either the photocoagulated or nonphotocoagulated half of the retina were used as the arterial and venous diameters in each rat.

Rolling leukocytes were defined as leukocytes that moved at a velocity slower than that of free-flowing leukocytes. The number of rolling leukocytes was calculated from the number of cells crossing a fixed area of the vessel per minute at a distance of 1 disc diameter from the optic disc center. The flux of rolling leukocytes was defined as the total number of rolling leukocytes along all major veins in either the photocoagulated or nonphotocoagulated half of the retina.

The number of leukocytes that accumulated in the retinal microcirculation was evaluated at 30 minutes after acridine orange injection, as described previously.6 Briefly, an observation area around the optic disc was determined by drawing a polygon surrounded by the adjacent major retinal vessels. The area was measured in pixels on a computer monitor, and the density of trapped leukocytes was calculated by dividing the number of trapped leukocytes, which were recognized as fluorescent dots, by the area of the observation region. The densities of leukocytes were calculated in four peripapillary observation areas in the nonphotocoagulated half of the fundus. The average density of individual areas was used as the number of leukocytes accumulated in the retinal microcirculation for each rat.

Measurement of Retinal Vessel Permeability Using Evans Blue
Retinal blood vessel leakage in rat was quantitated at 12, 24, 72, 168, and 336 hours after 400 spots of photocoagulation (n = 6 at each time point) using Evans blue dye (Sigma, St. Louis, MO), as previously described in detail.10 Albumin leakage into the retinal tissue was estimated by measuring extravasated Evans blue dye, which noncovalently binds to plasma albumin in the blood stream.11 The dye was dissolved in normal saline (30 mg/mL), sonicated for 5 minutes, and filtered through a 5-µm filter. Ninety minutes after injection of Evans blue (30 mg/kg) through a tail vein catheter, the chest cavity was opened and the left heart ventricle cannulated. Each rat was then perfused with citrate-buffered 1% paraformaldehyde (37°C) for 2 minutes to remove the dye, maintaining the physiological pressure of 120 mm Hg. The eyes were immediately enucleated and the nonphotocoagulated portions of the retina were carefully dissected with the aid of an operating microscope. Each retina was incubated in 0.3 mL formamide for 18 hours at 70°C to extract extravasated Evans blue. The extract was ultracentrifuged at a speed of 70,000 rpm for 45 minutes at a temperature of 4°C. The absorbance of the supernatant was then measured with a spectrophotometer at 620 nm, the absorption maximum for Evans blue in formamide. The concentration of dye in the extracts was calculated from a standard curve of Evans blue in formamide and normalized to the wet retinal weight.

Statistical Analysis
Data are expressed as the mean ± SEM. The data were analyzed using an analysis of variance, with posthoc comparisons tested with the Fisher protected least-significant difference test. Spearman’s rank correlation was used to relate the total number of photocoagulation applications to postlaser alterations, such as leukocyte behavior and vessel dilation. P < 0.05 was considered significant in all statistical analyses.


   Results
Top
 Abstract
 Introduction
 Methods
 Results
Discussion
 References
 
Diameters of Major Retinal Vessels
After laser photocoagulation, significant vasodilation occurred in arteries and veins in the treated half of the retina (Fig. 1A) . Figure 1B shows the time course of major retinal vessel diameters in the nonphotocoagulated retina at various time points after scatter laser photocoagulation. Photocoagulation caused similar vasodilation in arteries and veins in the untreated half of the retina. In the arteries, vasodilation occurred after photocoagulation and reached a peak at 24 to 48 hours (104%–107%; P < 0.01, compared with the control value). In the veins, vasodilation was more marked than in the arteries, with venous vasodilation reaching a peak 24 to 48 hours after photocoagulation (134%–135%; P < 0.01, compared with the control value).



View larger version (21K):
[in this window]
[in a new window]
  		Figure 1. Time course of diameters of major retinal arteries and veins after photocoagulation in the treated (A) and untreated (B) portions of the retina (n = 6 at each time point). Values are mean ± SEM. *P < 0.05 compared with control rats.

 
Leukocyte Rolling
Immediately after acridine orange had been infused intravenously, leukocytes were stained selectively among circulating blood cells. Laser photocoagulation induced active leukocyte-endothelial interactions along the major retinal veins in the coagulated half of the retina (Fig. 2A) . Among the many free-flowing leukocytes, some were observed to be rolling slowly along the major retinal veins, making intermittent adhesive contact with vascular endothelial cells. No rolling leukocytes were observed along any of the major retinal arteries throughout the experiments.



View larger version (17K):
[in this window]
[in a new window]
  		Figure 2. Time course of flux of rolling leukocytes along major retinal veins after photocoagulation in the treated (A) and untreated (B) portions of the retina (n = 6 at each time point). Data are mean ± SEM. *P < 0.05 compared with control rats.

 
Similarly, photocoagulation caused active leukocyte-endothelial interactions in the untreated half of the retina (Fig. 2B) . A small number of leukocytes were observed rolling along the venous walls at 4 hours after photocoagulation. The flux of rolling leukocytes substantially increased and peaked at 12 hours after photocoagulation (14.3 ± 4.5 cells/min per vessel; P < 0.01, compared with the control value). No rolling leukocytes were observed 168 hours after photocoagulation.

Leukocyte Accumulation
At 30 minutes after acridine orange injection, we identified the accumulated leukocytes in the retinal microcirculation as distinct fluorescent dots with the highest contrast. Very few leukocytes were seen to have accumulated in the retinal microcirculation of the control rats. Scatter laser photocoagulation induced substantial leukocyte accumulation in the untreated half of the retina. Figure 3 shows the time course of the number of leukocytes accumulated in the retinal microcirculation of the untreated half of the retina after photocoagulation of the other half. Whereas few leukocytes were identified in the control rats, accumulation of leukocytes began to increase with time in the nonphotocoagulated half of the retina and peaked at 24 hours after photocoagulation (47.5 ± 13.0 cells/mm2; P < 0.01, compared with the control value).



View larger version (19K):
[in this window]
[in a new window]
  		Figure 3. Time course of the number of leukocytes accumulated in the retinal microcirculation after photocoagulation in the untreated portions of the retina (n = 6 at each time point). Data are mean ± SEM. *P < 0.05 compared with control rats.

 
Examination of Dose Response to Total Number of Photocoagulation Spots
Figure 4 indicates the dose response to the total number of photocoagulation spots in vasodilation of major retinal arteries and veins in the nonphotocoagulated half of the retina at 24 hours after photocoagulation. Major retinal vessels in the untreated half of the retina showed significant vasodilation in proportion to the total number of photocoagulation spots (relative prevalence 0.83 and 0.40, P < 0.01 and P < 0.05, respectively). Similarly, inflammatory leukocyte-endothelial interactions, such as rolling (Fig. 5) and accumulation (Fig. 6) after photocoagulation in the nonphotocoagulated half of the retina, showed a dose response to the total number of photocoagulation spots (relative prevalence 0.52 and 0.54, respectively, P < 0.01).



View larger version (17K):
[in this window]
[in a new window]
  		Figure 4. Relationship between the number of scatter photocoagulation spots and the diameters of major retinal arteries and veins at 24 hours after photocoagulation in the untreated portions of the retina (n = 6 in each group). Data are mean ± SEM. *P < 0.05 compared with control rats.

 


View larger version (19K):
[in this window]
[in a new window]
  		Figure 5. Relationship between the number of scatter photocoagulation spots and the number of leukocytes rolling along major retinal veins at 24 hours after photocoagulation in the untreated portions of the retina (n = 6 in each group). Data are mean ± SEM. *P < 0.05 compared with control rats.

 


View larger version (15K):
[in this window]
[in a new window]
  		Figure 6. Relationship between the number of scatter photocoagulation spots and the number of leukocytes accumulated in the retinal microcirculation at 24 hours after photocoagulation in the untreated portions of the retina (n = 6 in each group). Data are mean ± SEM. *P < 0.05 compared with control rats.

 
Retinal Vessel Permeability in Nonphotocoagulated Retina
Figure 7 shows retinal vascular permeability in the nonphotocoagulated half of the retina at various time points after scatter photocoagulation. Retinal vascular permeability in the untreated half of the retina increased with time after photocoagulation. As early as 12 hours after photocoagulation, retinal vascular leakage increased to 142% in the untreated half of the retina (P = NS compared with the control value). Retinal vascular leakage increased to 360% at 168 hours after photocoagulation (P < 0.01, compared with the control value).



View larger version (16K):
[in this window]
[in a new window]
  		Figure 7. Time course of vascular permeability after photocoagulation in the untreated portions of the retina (n = 6 at each time point). Data are expressed as a percentage of control rat retina. Data are mean ± SEM. *P < 0.05 compared with control rats.

 

   Discussion
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
References
 
Blood-retinal barrier breakdown after scatter photocoagulation appears to contribute to various subsequent complications, primarily postlaser macular edema. In spite of its seriousness and frequency, however, little is known about the exact mechanisms of postlaser macular edema. Edema formation after scatter laser photocoagulation usually occurs inside the vascular arcade, especially in the macula, whereas photocoagulation is performed outside the arcade vessels. So far, although impaired blood-retinal barrier function after panretinal photocoagulation has been noted previously with fluorophotometry12 13 14 and magnetic resonance imaging,15 16 quantitative evaluation of the spatial distribution of barrier damage in the retina has been difficult. We therefore investigated the inflammatory response in the nonphotocoagulated half of the retina after half fundus photocoagulation.

Inflammatory leukocyte-endothelial interactions were observed in both the photocoagulated and the nonphotocoagulated halves of the retina in the present study. Recent experiments on leukocyte adhesion to the vascular endothelium have shown that leukocyte recruitment to the area of inflammation takes place through a multistep process mediated by distinct adhesion molecules.17 18 An investigation using the fluorophotometric technique developed by Taguchi et al.19 has demonstrated that hydrogen peroxides were diffused into the vitreous after retinal scatter photocoagulation. Hydrogen peroxides was found to induce upregulation of adhesion molecules on the vascular endothelium and subsequent leukocyte-endothelial interactions.20 Accordingly, scatter photocoagulation may cause inflammatory leukocyte behavior, such as rolling and accumulation in the nonphotocoagulated retina through oxidative stress-induced upregulation of adhesion molecules on the vascular endothelium.

In contrast to the beneficial role of leukocytes with immunologic and antimicrobial activity, intense examinations have revealed that they are involved in the pathogenesis of various pathogenic conditions,21 including ischemia-reperfusion injury22 and diabetic retinopathy.23 24 Under such conditions, leukocytes accumulated in the microcirculation exhibit their cytotoxic properties by blocking blood flow25 and by releasing oxygen free radicals, proteolytic enzymes such as elastase or collagenase, and various inflammatory cytokines.21 Moreover, recent evidence suggests that leukocytes play a critical role in disrupting the microvascular barrier in various organs.3 26 27 28 29 30 31 32 These reports have suggested that, among several phases of leukocyte-endothelial interaction mediated by distinct adhesion molecules, leukocyte-endothelial contact, such as leukocyte adhesion on the vascular endothelium and subsequent leukocyte extravasation, may be responsible for increased microvascular permeability under inflammatory conditions.

Similar to findings in other organs, in the retina, blood-retinal barrier breakdown has been suggested to occur as a consequence of leukocyte infiltration under various pathologic conditions.23 33 34 35 A histologic study using a rat model of experimental autoimmune uveoretinitis demonstrated that infiltrated leukocytes cause blood-retinal breakdown in ocular inflammation.33 Another study suggested that interleukin-1ß-induced blood-retinal barrier breakdown is significantly inhibited by leukocyte depletion.34 In addition, Miyamoto et al.23 35 have reported that prevention of increased leukocyte entrapment by inhibiting intercellular adhesion molecule-1 with its antibody reduces vascular leakage induced by diabetes or VEGF injection. Thus, the cytotoxic properties of leukocytes accumulated in the retinal microcirculation after photocoagulation may contribute to increased retinal vascular permeability in the nonphotocoagulated retina. As shown in Figures 2B and 3 , the numbers of rolling and accumulated leukocytes began to increase substantially after scatter photocoagulation, with respective peaks at 12 and 24 hours. So far, little information is available about changes in the earlier phase that could cause impairment of barrier function. In our study, leukocyte accumulation in the retinal microcirculation occurred during a comparatively early phase after scatter photocoagulation.

To evaluate the spatial characteristics of postlaser vascular permeability, we used Evans blue in the present study. After half fundus photocoagulation treatment, vascular permeability due to the absence of macula was assessed in the whole portions of nonphotocoagulated retina in rat. Our results demonstrated a significant increase of vascular permeability in the nonphotocoagulated portions of the retina after half fundus photocoagulation. Contrary to our results, in an immunohistochemical study, Shiga et al.36 suggested that there was no detectable breakdown of the inner barrier after panretinal photocoagulation. In their study, however, only 200 spots of scatter photocoagulation were applied to monkey eyes. On the other hand, our study demonstrated that a significant dose response with total number of photocoagulation spots was present in the postlaser inflammation in the retinal microcirculation. This dose response may account for some of the conflicting results reported by Shiga et al.36 and us.

As shown in Figures 1A and 1B , retinal vessels showed remarkable vasodilation after photocoagulation. The vascular endothelium simultaneously produce a number of vasodilating factors (e.g., nitric oxide and prostaglandin-I2) and vasoconstricting factors (e.g., endothelin and thromboxane-A2), and their interactions mediate vascular tone.37 However, the inflammatory stimulus upregulates inducible-nitric oxide synthetase in leukocytes, which produce large amounts of nitric oxide, in contrast to the relatively small amounts of nitric oxide produced by constitutive nitric oxide synthetase in the vascular endothelium.38 Leukocytes accumulating after scatter photocoagulation and producing nitric oxide are likely to contribute to significant vasodilation in major retinal arteries and veins.

In summary, scatter laser photocoagulation increased leukocyte rolling and subsequent accumulation in both the photocoagulated and nonphotocoagulated portions of the retina after half fundus scatter photocoagulation. The accumulated leukocytes may be involved in the augmented vascular permeability in the untreated retina, resulting in retinal edema after photocoagulation.


   Footnotes
 
Supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan.

Submitted for publication August 9, 2001; revised November 26, 2001; accepted December 13, 2001.

Commercial relationships policy: N.

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Corresponding author: Junichi Kiryu, Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan; kiryu{at}kuhp.kyoto-u.ac.jp


   References
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. McDonald, HR, Schatz, H. (1985) Macular edema following panretinal photocoagulation Retina 5,5-10[Medline][Order article via Infotrieve]
  2. Tsujikawa, A, Kiryu, J, Dong, J, et al (1999) Quantitative analysis of diabetic macular edema after scatter laser photocoagulation with the scanning retinal thickness analyzer Retina 19,59-64[Medline][Order article via Infotrieve]
  3. Del-Maschio, A, Zanetti, A, Corada, M, et al (1996) Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions J Cell Biol 135,497-510[Abstract/Free Full Text]
  4. Kimura, H, Kiryu, J, Nishiwaki, H, Ogura, Y. (1995) A new fluorescent imaging procedure in vivo for evaluation of the retinal microcirculation in rats Curr Eye Res 14,223-228[Medline][Order article via Infotrieve]
  5. Nishiwaki, H, Ogura, Y, Kimura, H, Kiryu, J, Honda, Y. (1995) Quantitative evaluation of leukocyte dynamics in retinal microcirculation Invest Ophthalmol Vis Sci 36,123-130[Abstract/Free Full Text]
  6. Nishiwaki, H, Ogura, Y, Kimura, H, Kiryu, J, Miyamoto, K, Matsuda, N. (1996) Visualization and quantitative analysis of leukocyte dynamics in retinal microcirculation of rats Invest Ophthalmol Vis Sci 37,1341-1347[Abstract/Free Full Text]
  7. Tsujikawa, A, Ogura, Y, Hiroshiba, N, et al (1999) Retinal ischemia-reperfusion injury attenuated by blocking of adhesion molecules of vascular endothelium Invest Ophthalmol Vis Sci 40,1183-1190[Abstract/Free Full Text]
  8. Nonaka, A, Kiryu, J, Tsujikawa, A, et al (2000) Administration of 17ß-estradiol attenuates retinal ischemia-reperfusion injury in rats Invest Ophthalmol Vis Sci 41,2689-2696[Abstract/Free Full Text]
  9. Hiroshiba, N, Ogura, Y, Nishiwaki, H, Miyamoto, K, Honda, Y. (1998) Alterations of retinal microcirculation in response to scatter photocoagulation Invest Ophthalmol Vis Sci 39,769-776[Abstract/Free Full Text]
  10. Xu, Q, Qaum, T, Adamis, AP. (2001) Sensitive blood-retinal barrier breakdown quantitation using Evans blue Invest Ophthalmol Vis Sci 42,789-794[Abstract/Free Full Text]
  11. Rawson, RA. (1943) The binding of T-1824 and structurally related diazo dyes by plasma proteins Am J Physiol 138,708-717[Free Full Text]
  12. Noth, JM, Vygantas, C, Cunha-Vaz, JG. (1978) Vitreous fluorophotometry evaluation of xenon photocoagulation Invest Ophthalmol Vis Sci 17,1206-1209[Abstract/Free Full Text]
  13. Watanabe, M, Noumi, T, Fujii, M, Shibuya, Y, Setogawa, T. (1985) Vitreous fluorophotometry after the argon laser photocoagulation in monkey’s eyes [in Japanese] J Jpn Ophthalmol Soc 89,323-334
  14. Tsukahara, Y, Ogura, Y, Miura, M, Kondo, T. (1987) Effect of argon laser photocoagulation on the permeability of the blood-retinal barrier Ophthalmologica 194,27-33[Medline][Order article via Infotrieve]
  15. Sen, HA, Berkowitz, BA, Ando, N, de Juan, E, Jr (1992) In vivo imaging of breakdown of the inner and outer blood-retinal barriers Invest Ophthalmol Vis Sci 33,3507-3512[Abstract/Free Full Text]
  16. Wilson, CA, Berkowitz, BA, Sato, Y, Ando, N, Handa, JT, de Juan, E, Jr (1992) Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation Arch Ophthalmol 110,1155-1159[Abstract/Free Full Text]
  17. Bevilacqua, MP, Nelson, RM. (1993) Selectins J Clin Invest 91,379-387
  18. Osborn, L. (1990) Leukocyte adhesion to endothelium in inflammation Cell 62,3-6[Medline][Order article via Infotrieve]
  19. Taguchi, H, Ogura, Y, Takanashi, T, Hashizoe, M, Honda, Y. (1998) Fluorophotometric detection of intravitreal peroxides after panretinal laser photocoagulation Invest Ophthalmol Vis Sci 39,358-363[Abstract/Free Full Text]
  20. Gaboury, JP, Anderson, DC, Kubes, P. (1994) Molecular mechanisms involved in superoxide- induced leukocyte-endothelial cell interactions in vivo Am J Physiol 266,H637-H642[Abstract/Free Full Text]
  21. Schmid-Schonbein, GW. (1993) The damaging potential of leukocyte activation in the microcirculation Angiology 44,45-56
  22. Kochanek, PM, Hallenbeck, JM. (1992) Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke Stroke 23,1367-1379[Abstract/Free Full Text]
  23. Miyamoto, K, Khosrof, S, Bursell, SE, et al (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition Proc Natl Acad Sci USA 96,10836-10841[Abstract/Free Full Text]
  24. Schroder, S, Palinski, W, Schmid-Schonbein, GW. (1991) Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy Am J Pathol 139,81-100[Abstract]
  25. Hatchell, DL, Wilson, CA, Saloupis, P. (1994) Neutrophils plug capillaries in acute experimental retinal ischemia Microvasc Res 47,344-354[Medline][Order article via Infotrieve]
  26. Hernandez, LA, Grisham, MB, Twohig, B, Arfors, KE, Harlan, JM, Granger, DN. (1987) Role of neutrophils in ischemia-reperfusion-induced microvascular injury Am J Physiol 253,H699-H703[Abstract/Free Full Text]
  27. Carden, DL, Smith, JK, Korthuis, RJ. (1990) Neutrophil-mediated microvascular dysfunction in postischemic canine skeletal muscle: role of granulocyte adherence Circ Res 66,1436-1444[Abstract/Free Full Text]
  28. Kurose, I, Anderson, DC, Miyasaka, M, et al (1994) Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage Circ Res 74,336-343[Abstract/Free Full Text]
  29. Marcus, BC, Hynes, KL, Gewertz, BL. (1997) Loss of endothelial barrier function requires neutrophil adhesion Surgery 122,420-426[Medline][Order article via Infotrieve]
  30. Anthony, DC, Bolton, SJ, Fearn, S, Perry, VH. (1997) Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats Brain 120,435-444[Abstract/Free Full Text]
  31. Korthuis, RJ, Gute, DC. (1997) Postischemic leukocyte/endothelial cell interactions and microvascular barrier dysfunction in skeletal muscle: cellular mechanisms and effect of Daflon 500 mg Int J Microcirc Clin Exp 1,11-17
  32. Bolton, SJ, Anthony, DC, Perry, VH. (1998) Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo Neuroscience 86,1245-1257[Medline][Order article via Infotrieve]
  33. Lightman, S, Greenwood, J. (1992) Effect of lymphocytic infiltration on the blood-retinal barrier in experimental autoimmune uveoretinitis Clin Exp Immunol 88,473-477[Medline][Order article via Infotrieve]
  34. Bamforth, SD, Lightman, SL, Greenwood, J. (1997) Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine Am J Pathol 150,329-340[Abstract]
  35. Miyamoto, K, Khosrof, S, Bursell, SE, et al (2000) Vascular endothelial growth factor (VEGF)- induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1) Am J Pathol 156,1733-1739[Abstract/Free Full Text]
  36. Shiga, S, Hayashi, H, Oshima, K. (1994) Immunohistochemical localization of blood-retinal barrier breakdown after argon laser photocoagulation in the monkey retina [in Japanese] J Jpn Ophthalmol Soc 98,463-468
  37. Akopov, S, Sercombe, R, Seylaz, J. (1996) Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions Cerebrovasc Brain Metab Rev 8,11-94[Medline][Order article via Infotrieve]
  38. Moncada, S. (1992) The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway Acta Physiol Scand 145,201-227[Medline][Order article via Infotrieve]



This article has been cited by other articles:


Home page
 Br. J. Ophthalmol.Home page
N Unoki, K Nishijima, M Kita, K Suzuma, D Watanabe, H Oh, T Kimura, A Sakamoto, and N Yoshimura
Randomised controlled trial of posterior sub-Tenon triamcinolone as adjunct to panretinal photocoagulation for treatment of diabetic retinopathy
Br. J. Ophthalmol., June 1, 2009; 93(6): 765 - 770.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
A Takahashi, T Nagaoka, E Sato, and A Yoshida
Effect of panretinal photocoagulation on choroidal circulation in the foveal region in patients with severe diabetic retinopathy
Br. J. Ophthalmol., October 1, 2008; 92(10): 1369 - 1373.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. Mizuno, A. Matsubara, and Y. Ogura
Effect of Posterior Sub-Tenon Administration of Triamcinolone Acetonide on Leukocyte Dynamics in Rat Retinal Microcirculation after Panretinal Photocoagulation
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 2127 - 2133.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M. Shimura, T. Nakazawa, K. Yasuda, T. Shiono, and K. Nishida
Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema
Br. J. Ophthalmol., April 1, 2007; 91(4): 449 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
F. Bandello, A. Polito, D. R. Pognuz, P. Monaco, A. Dimastrogiovanni, and J. Paissios
Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy.
Arch Ophthalmol, May 1, 2006; 124(5): 643 - 650.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. Musashi, J. Kiryu, K. Miyamoto, S. Miyahara, H. Katsuta, H. Tamura, F. Hirose, and N. Yoshimura
Thrombin Inhibitor Reduces Leukocyte-Endothelial Cell Interactions and Vascular Leakage after Scatter Laser Photocoagulation
Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2561 - 2566.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Miyahara, J. Kiryu, K. Miyamoto, H. Katsuta, F. Hirose, H. Tamura, K. Musashi, Y. Honda, and N. Yoshimura
In Vivo Three-Dimensional Evaluation of Leukocyte Behavior in Retinal Microcirculation of Mice
Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4197 - 4201.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nonaka, A.
Right arrow Articles by Ogura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nonaka, A.
Right arrow Articles by Ogura, Y.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS